CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast - Karonen - British Journal of Clinical Pharmacology - Wiley Online Library

Links shared publicly online about this topic.

  • 61
    total visits

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast - Karonen - British Journal of Clinical Pharmacology - Wiley Online Library

onlinelibrary.wiley.com —

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast - Karonen - British Journal of Clinical Pharmacology - Wiley Online Library

View full resource at onlinelibrary.wiley.com

Tags: Asthma Medication, Singulair, Pharmacokinetics

  • Share

Most Recently Shared on August 19, 2011 at 1:13 pm By:

JuanCIvancevich Juan C. Ivancevich, MD

CYP2C8 is the dominant enzyme in the biotransformation of montelukast in humans http://t.co/u8fteYp

9 months ago...

Reply

Retweet

Favorite

Advertisement